A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Amid ongoing controversy, U.S. Sen. Maggie Hassan (D-N.H.) is investigating GSK for replacing a popular asthma inhaler with a ...

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor ...

Rise and shine, another busy day is on the way. We can tell because the official mascots got an early start chasing down cats, squirrels, and other creatures darting about the Pharmalot campus.

Emerging as the leader in ultra-rare diseases treatments, Alexion has been a huge success story, bringing breakthroughs to disabling and fatal conditions. But this success brings pressure from ...

(Pharmalot) Reference links: FDA news release. ClaireMorris. 22 April, 2013. Bookmark this. Editor's Picks. Gilead's twice-yearly PrEP drug is cleared by FDA .

By Grace Vitaglione. Jennifer Burch is a second-generation pharmacist who’s been working at Central Pharmacy in Durham since she was a teen. Some of her current customers have been coming to the store ...

That's been going on for a long time. Philippines also. There's an under-economy of monetizing a lot of the discarded garments donated to charity in North America, that is then alleged to be sold on ...